XPH ETF
State Street SPDR S&P Pharmaceuticals ETF
AMLX is XPH's largest holding at 3.82% of the fund as of Sep 15, 2026. XPH is State Street SPDR S&P Pharmaceuticals ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Share chg | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | A | Amylyx Pharmaceuticals IncHealth Care · Pharmaceuticals | 3.82% | 3.8% | 711,095 | +156.6K | Health Care | Pharmaceuticals |
| 2 | M | Mbx Biosciences IncHealth Care · Biotechnology | 3.10% | 6.9% | 308,853 | +68.0K | Health Care | Biotechnology |
| Share changes, sector and industry · Pro | ||||||||
| 3 | O | Omeros Corp | 2.92% | 9.8% | 938,367 | |||
| 4 | — | Definium Therapeutics, Inc. Common Shares | 2.72% | 12.6% | 411,848 | |||
| 5 | E | Enliven Therapeutics Inc | 2.39% | 15.0% | 258,685 | |||
| 6 | C | Corcept Therapeutics Inc | 2.35% | 17.3% | 122,522 | |||
| 7 | E | Edgewise Therapeutics Inc. | 2.20% | 19.5% | 290,746 | |||
| 8 | E | Eton Pharmaceuticals Inc. | 2.19% | 21.7% | 226,088 | |||
| 9 | N | Nuvation Bio Inc | 2.16% | 23.9% | 2,089,813 | |||
| 10 | T | Tarsus Pharmaceuticals Inc | 2.11% | 26.0% | 156,216 | |||
| 11 | N | Nektar Therapeutics Class A | 2.00% | 28.0% | 168,569 | |||
| 12 | P | Perrigo Company Plc Ordinary Shares | 1.99% | 29.9% | 856,880 | |||
| 13 | M | Merck & Company Inc | 1.97% | 31.9% | 80,371 | |||
| 14 | O | Ocular Therapeutix Inc | 1.95% | 33.9% | 1,095,119 | |||
| 15 | T | Trevi Therapeutics Inc. | 1.93% | 35.8% | 714,280 | |||
| 16 | H | Harmony Biosciences, Llc | 1.90% | 37.7% | 269,767 | |||
| 17 | L | Ligand Pharmaceuticals, Inc. | 1.87% | 39.6% | 38,557 | |||
| 18 | B | Bristol-Myers Squibb Co. | 1.86% | 41.4% | 172,146 | |||
| 19 | A | Amneal Pharmaceuticals Inc. | 1.81% | 43.2% | 624,762 | |||
| 20 | J | Johnson & Johnson - | 1.81% | 45.0% | 40,133 | |||
| 21 | — | Pacira Pharm Inc | 1.76% | 46.8% | 408,683 | |||
| 22 | P | Pfizer Inc | 1.76% | 48.6% | 373,880 | |||
| 23 | R | Royalty Pharma Plc Class A Ordinary Share | 1.75% | 50.3% | 175,556 | |||
| 24 | J | Jazz Pharmaceuticals Plc. | 1.74% | 52.1% | 41,681 | |||
| 25 | M | Veradermics Inc | 1.73% | 53.8% | 102,940 | |||
| 26 | V | Viatris Inc. | 1.70% | 55.5% | 606,933 | |||
| 27 | — | Liquidia Technologies Inc | 1.66% | 57.1% | 146,688 | |||
| 28 | O | Organon & Co | 1.66% | 58.8% | 715,347 | |||
| 29 | E | Elanco Animal Health, Inc Cvr | 1.65% | 60.5% | 418,511 | |||
| 30 | M | Maze Therapeutics Inc | 1.63% | 62.1% | 389,173 | |||
| 31 | R | Rapport Therapeutics, Inc. | 1.61% | 63.7% | 216,455 | |||
| 32 | L | Eli Lilly & Co. | 1.60% | 65.3% | 8,423 | |||
| 33 | A | Amphastar Pharmaceuticals Inc | 1.57% | 66.9% | 388,873 | |||
| 34 | — | Harrow Health Inc | 1.56% | 68.4% | 266,612 | |||
| 35 | P | Prestige Consumer Healthcare Inc | 1.56% | 70.0% | 194,817 | |||
| 36 | P | Phibro Animal Health Corp | 1.55% | 71.5% | 256,505 | |||
| 37 | A | Alto Neuroscience, Inc., Series C | 1.52% | 73.1% | 278,462 | |||
| 38 | S | Supernus Pharmaceuticals Inc | 1.50% | 74.6% | 212,272 | |||
| 39 | — | Indivior Pharmaceuticals, Inc. Ordinary Shares | 1.47% | 76.0% | 251,282 | |||
| 40 | A | Axsome Therapeutics Inc | 1.46% | 77.5% | 38,854 | |||
| 41 | I | Innoviva Inc | 1.46% | 78.9% | 416,145 | |||
| 42 | Z | Zoetis Inc, Class A | 1.46% | 80.4% | 117,743 | |||
| 43 | — | Xeris Pharmaceuticals Inc | 1.40% | 81.8% | 1,102,839 | |||
| 44 | A | Ani Pharmaceuticals Inc | 1.40% | 83.2% | 116,938 | |||
| 45 | A | Arvinas Inc | 1.35% | 84.6% | 941,253 | |||
| 46 | W | Wave Life Sciences Ltd | 1.32% | 85.9% | 1,691,050 | |||
| 47 | S | Septerna Inc | 1.21% | 87.1% | 185,477 | |||
| 48 | L | Lb Pharmaceuticals Inc. | 1.17% | 88.3% | 153,965 | |||
| 49 | Z | Zevra Therapeutics Inc | 1.10% | 89.4% | 540,767 | |||
| 50 | C | Cormedix Inc | 1.07% | 90.4% | 804,915 | |||
| More holdings · Pro | ||||||||
XPH ETF All Holdings
XPH holdings total 64 positions. The top 10 holdings account for 26.0% of the fund, led by Amylyx Pharmaceuticals Inc at 3.8%, Mbx Biosciences Inc at 3.1%, Omeros Corp Com at 2.9%.
XPH portfolio concentration is well-diversified, with the top 10 representing 26.0% of total assets. The largest sector exposure is Health Care at 84.7%.
XPH sectors provide a detailed breakdown. XPH overlap shows how holdings compare to other funds in your portfolio.
XPH ETF Holdings
64 of 64 holdings
- 1
Amylyx Pharmaceuticals Inc
AMLXHealth Care3.82% - 2
Mbx Biosciences Inc
MBXHealth Care3.10% - 3
Omeros Corp Com
OMERHealth Care2.92% - 4
Definium Therapeutics, Inc. Common Shares
DFTX:CAUnknown2.72% - 5
Enliven Therapeutics Inc
ELVNHealth Care2.39% - 6
Corcept Therapeutics Incorporated
CORTHealth Care2.35% - 7
Edgewise Therapeutics Inc.
EWTXHealth Care2.20% - 8
Eton Pharmaceuticals Inc.
ETONHealth Care2.19% - 9
Nuvation Bio Inc
NUVBHealth Care2.16% - 10
Tarsus Pharmaceuticals Inc
TARSHealth Care2.11% - 11
Nektar Therapeutics Class A
NKTRUnknown2.00% - 12
Perrigo Company Plc Ordinary Shares
PRGOConsumer Staples1.99% - 13
Merck & Company Inc
MRKHealth Care1.97% - 14
Ocular Therapeutix Inc
OCULHealth Care1.95% - 15
Trevi Therapeutics Inc.
TRVIHealth Care1.93% - 16
Harmony Biosciences, Llc
HRMYHealth Care1.90% - 17
Ligand Pharmaceuticals, Inc.
LGNDHealth Care1.87% - 18
Bristol-Myers Squibb Co.
BMYHealth Care1.86% - 19
Amneal Pharmaceuticals Inc.
AMRXHealth Care1.81% - 20
Johnson & Johnson - Common
JNJHealth Care1.81% - 21
Pacira Pharm Inc
PCRXHealth Care1.76% - 22
Pfizer Inc
PFEHealth Care1.76% - 23
Royalty Pharma Plc Class A Ordinary Share
RPD:DUFinancials1.75% - 24
Jazz Pharmaceuticals Plc.
JAZZHealth Care1.74% - 25
Veradermics Inc
MANEUnknown1.73% - 26
Viatris Inc.
VTRSHealth Care1.70% - 27
Liquidia Technologies Inc
LQDAHealth Care1.66% - 28
Organon & Co
OGNHealth Care1.66% - 29
Elanco Animal Health, Inc Cvr
ELANHealth Care1.65% - 30
Maze Therapeutics Inc
MAZEHealth Care1.63% - 31
Rapport Therapeutics, Inc.
RAPPHealth Care1.61% - 32
Eli Lilly & Co.
LLYHealth Care1.60% - 33
Amphastar Pharmaceuticals Inc
AMPHHealth Care1.57% - 34
Harrow Health Inc Com
HROWHealth Care1.56% - 35
Prestige Consumer Healthcare Inc
PBHConsumer Staples1.56% - 36
Phibro Animal Health Corp
PAHCHealth Care1.55% - 37
Alto Neuroscience, Inc., Series C
ANROHealth Care1.52% - 38
Supernus Pharmaceuticals Inc
SUPNHealth Care1.50% - 39
Indivior Pharmaceuticals, Inc. Ordinary Shares
INDV:MBUnknown1.47% - 40
Axsome Therapeutics Inc
AXSMHealth Care1.46% - 41
Innoviva Inc
INVAHealth Care1.46% - 42
Zoetis Inc, Class A
ZTSHealth Care1.46% - 43
Xeris Pharmaceuticals Inc Com
XERSHealth Care1.40% - 44
Ani Pharmaceuticals Inc
ANIPHealth Care1.40% - 45
Arvinas Inc
ARVNHealth Care1.35% - 46
Wave Life Sciences Ltd
WVEHealth Care1.32% - 47
Septerna Inc
SEPNHealth Care1.21% - 48
Lb Pharmaceuticals Inc.
LBRXUnknown1.17% - 49
Zevra Therapeutics Inc
ZVRAHealth Care1.10% - 50
Cormedix Inc Com
CRMDHealth Care1.07% - 51
Collegium Pharmaceutical Inc
COLLHealth Care1.06% - 52
Theravance Biopharma Inc
TBPHHealth Care1.02% - 53
Aclaris Therapeutics Inc
ACRSHealth Care0.96% - 54
Ara Us Hospitality Trust
AQSTHealth Care0.94% - 55
Phathom Pharmaceuticals Inc Phat
PHATHealth Care0.87% - 56
Fulcrum Therapeutics Inc Com
FULCHealth Care0.76% - 57
Alumis Inc Common Stock USD 0.0001
ALMSIndustrials0.74% - 58
Relmada Therapeutics Inc Common Stock
RLMDHealth Care0.74% - 59
Evolus Inc
EOLSHealth Care0.63% - 60
Eyepoint Pharmaceuticals Inc.(eypt)
EYPTHealth Care0.56% - 61
Lexicon Pharmaceut Com New
LXRXHealth Care0.56% - 62
Bioage Labs Inc Common Stock Usd.00001
BIOAHealth Care0.55% - 63
Ssi Us Gov Money Market Class
NMFUnknown0.12% - 64
Contra Esperion Therap
Other0.01%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Amylyx Pharmaceuticals Inc | AMLX | 3.820% | ||
| 2 | Mbx Biosciences Inc | MBX | 3.100% | ||
| 3 | Omeros Corp Com | OMER | 2.920% | ||
| 4 | Definium Therapeutics, Inc. Common Shares | DFTX:CA | 2.720% | ||
| 5 | Enliven Therapeutics Inc | ELVN | 2.390% | ||
| 6 | Corcept Therapeutics Incorporated | CORT | 2.350% | ||
| 7 | Edgewise Therapeutics Inc. | EWTX | 2.200% | ||
| 8 | Eton Pharmaceuticals Inc. | ETON | 2.190% | ||
| 9 | Nuvation Bio Inc | NUVB | 2.160% | ||
| 10 | Tarsus Pharmaceuticals Inc | TARS | 2.110% | ||
| 11 | Nektar Therapeutics Class A | NKTR | 2.000% | ||
| 12 | Perrigo Company Plc Ordinary Shares | PRGO | 1.990% | ||
| 13 | Merck & Company Inc | MRK | 1.970% | ||
| 14 | Ocular Therapeutix Inc | OCUL | 1.950% | ||
| 15 | Trevi Therapeutics Inc. | TRVI | 1.930% | ||
| 16 | Harmony Biosciences, Llc | HRMY | 1.900% | ||
| 17 | Ligand Pharmaceuticals, Inc. | LGND | 1.870% | ||
| 18 | Bristol-Myers Squibb Co. | BMY | 1.860% | ||
| 19 | Amneal Pharmaceuticals Inc. | AMRX | 1.810% | ||
| 20 | Johnson & Johnson - Common | JNJ | 1.810% | ||
| 21 | Pacira Pharm Inc | PCRX | 1.760% | ||
| 22 | Pfizer Inc | PFE | 1.760% | ||
| 23 | Royalty Pharma Plc Class A Ordinary Share | RPD:DU | 1.750% | ||
| 24 | Jazz Pharmaceuticals Plc. | JAZZ | 1.740% | ||
| 25 | Veradermics Inc | MANE | 1.730% | ||
| 26 | Viatris Inc. | VTRS | 1.700% | ||
| 27 | Liquidia Technologies Inc | LQDA | 1.660% | ||
| 28 | Organon & Co | OGN | 1.660% | ||
| 29 | Elanco Animal Health, Inc Cvr | ELAN | 1.650% | ||
| 30 | Maze Therapeutics Inc | MAZE | 1.630% | ||
| 31 | Rapport Therapeutics, Inc. | RAPP | 1.610% | ||
| 32 | Eli Lilly & Co. | LLY | 1.600% | ||
| 33 | Amphastar Pharmaceuticals Inc | AMPH | 1.570% | ||
| 34 | Harrow Health Inc Com | HROW | 1.560% | ||
| 35 | Prestige Consumer Healthcare Inc | PBH | 1.560% | ||
| 36 | Phibro Animal Health Corp | PAHC | 1.550% | ||
| 37 | Alto Neuroscience, Inc., Series C | ANRO | 1.520% | ||
| 38 | Supernus Pharmaceuticals Inc | SUPN | 1.500% | ||
| 39 | Indivior Pharmaceuticals, Inc. Ordinary Shares | INDV:MB | 1.470% | ||
| 40 | Axsome Therapeutics Inc | AXSM | 1.460% | ||
| 41 | Innoviva Inc | INVA | 1.460% | ||
| 42 | Zoetis Inc, Class A | ZTS | 1.460% | ||
| 43 | Xeris Pharmaceuticals Inc Com | XERS | 1.400% | ||
| 44 | Ani Pharmaceuticals Inc | ANIP | 1.400% | ||
| 45 | Arvinas Inc | ARVN | 1.350% | ||
| 46 | Wave Life Sciences Ltd | WVE | 1.320% | ||
| 47 | Septerna Inc | SEPN | 1.210% | ||
| 48 | Lb Pharmaceuticals Inc. | LBRX | 1.170% | ||
| 49 | Zevra Therapeutics Inc | ZVRA | 1.100% | ||
| 50 | Cormedix Inc Com | CRMD | 1.070% | ||
| 51 | Collegium Pharmaceutical Inc | COLL | 1.060% | ||
| 52 | Theravance Biopharma Inc | TBPH | 1.020% | ||
| 53 | Aclaris Therapeutics Inc | ACRS | 0.960% | ||
| 54 | Ara Us Hospitality Trust | AQST | 0.940% | ||
| 55 | Phathom Pharmaceuticals Inc Phat | PHAT | 0.870% | ||
| 56 | Fulcrum Therapeutics Inc Com | FULC | 0.760% | ||
| 57 | Alumis Inc Common Stock USD 0.0001 | ALMS | 0.740% | ||
| 58 | Relmada Therapeutics Inc Common Stock | RLMD | 0.740% | ||
| 59 | Evolus Inc | EOLS | 0.630% | ||
| 60 | Eyepoint Pharmaceuticals Inc.(eypt) | EYPT | 0.560% | ||
| 61 | Lexicon Pharmaceut Com New | LXRX | 0.560% | ||
| 62 | Bioage Labs Inc Common Stock Usd.00001 | BIOA | 0.550% | ||
| 63 | Ssi Us Gov Money Market Class | NMF | 0.120% | ||
| 64 | Contra Esperion Therap | - | 0.010% |











































